Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypoplastic acute leukemia

S W Needleman, C P Burns, F R Dick

    Cancer
    |September 15, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Hypoplastic acute leukemia, a rare form affecting older adults, presents with low bone marrow cellularity. Supportive care alone may lead to prolonged survival in some patients, while aggressive chemotherapy has limited success.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Peripheral T-Cell Lymphoma-A Brief Review.

    Leukemia & lymphoma·2016
    Same author

    Autologous and allogeneic hematopoietic stem cell transplantation in follicular lymphoma.

    Expert opinion on biological therapy·2015
    Same author

    Religious orientation and coping with cancer.

    Journal of religion and health·2013
    Same author

    Factors affecting the development of atrial fibrillation and atrial flutter (AF/AFL) following autologous hematopoietic SCT (auto-HSCT).

    Bone marrow transplantation·2012
    Same author

    Chromosomal abnormalities in malignant lymphoma and Hodgkin's disease.

    Leukemia & lymphoma·2011
    Same author

    The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-Cell Lymphoma Project.

    Annals of oncology : official journal of the European Society for Medical Oncology·2009
    Same journal

    Toward exercise as standard care for older cancer survivors.

    Cancer·2026
    Same journal

    Maintenance therapy in gynecologic malignancies: Current and future state.

    Cancer·2026
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    Same journal

    Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

    Cancer·2026
    See all related articles

    Area of Science:

    • Hematology
    • Oncology

    Background:

    • Acute leukemia typically presents with hypercellular bone marrow.
    • Reports of acute leukemia with hypocellular bone marrow are infrequent.

    Purpose of the Study:

    • To identify and characterize patients with acute leukemia and hypocellular bone marrow.
    • To evaluate the clinical features, outcomes, and treatment responses in this specific patient cohort.

    Main Methods:

    • Retrospective analysis of patients diagnosed with acute leukemia over a six-year period.
    • Inclusion criteria: blast cells + promyelocytes >30% and marrow cellularity ≤50% on needle biopsy.
    • Analysis of clinical presentation, laboratory findings, FAB classification, treatment, and survival.

    Main Results:

    Related Experiment Videos

    • 15 out of 195 patients (7.7%) met the criteria for hypocellular acute leukemia.
    • Median age was 68 years; most patients were pancytopenic with low white blood cell counts and circulating blasts were often absent.
    • Morphology was predominantly myeloid (FAB M1, M2, M4), with one L2 case. Median survival was seven months.
    • Supportive care alone in seven patients resulted in two surviving over a year.
    • Aggressive chemotherapy in eight patients led to a low success rate, with five deaths from treatment complications and two achieving durable remission.

    Conclusions:

    • Hypoplastic acute leukemia appears to be a distinct entity, predominantly affecting older individuals with myeloid leukemia.
    • Remission induction therapy for severely ill patients has a low success rate.
    • Prolonged survival may be achievable with supportive care alone in select cases.